加载中
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
常规交易时段
US$9.07
−US$0.21 · -2.26%
盘中时间采用ET。市场数据可能有所延迟。
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
日内区间
当前US$9.07
52周区间
当前US$9.07
盘中时间采用ET。市场数据可能有所延迟。
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
日内区间
当前US$9.07
52周区间
当前US$9.07
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2023年2月15日 | 1:15 | — | — |
已生效 2023年2月15日
1:15
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI133.52万0.00%2.3万亿 USD0.03%US$380.86-0.19%
Vanguard Extended Market ETFVXF64.91万0.00%954亿 USD0.05%US$231.81-0.73%
State Street SPDR S&P International Small Cap ETFGWX54.52万0.06%9.15亿 USD0.40%US$45.18-0.18%
iShares Micro-Cap ETFIWC17.95万0.01%13.17亿 USD0.60%US$180.36-0.72%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFState Street SPDR S&P International Small Cap ETFGWXiShares Micro-Cap ETFIWCAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
